Zura Bio (ZURA) Total Non-Current Liabilities (2021 - 2024)
Zura Bio (ZURA) posted quarterly Total Non-Current Liabilities of $18.2 million for Q3 2024, up 7.24% year-over-year from $17.0 million in Q4 2023, and up 21.04% quarter-over-quarter from $15.1 million in Q2 2024.
Zura Bio (ZURA) Total Non-Current Liabilities (2021 - 2024) Analysis & Trends
Zura Bio's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $18.2 million for Q3 2024.
- In Q3 2024, Total Non-Current Liabilities rose 7.24% year-over-year to $18.2 million; the TTM figure through Sep 2024 stood at $18.2 million (up 7.24% YoY), while the FY2023 annual figure was $20.3 million, up 358.49% from the prior year.
- Total Non-Current Liabilities for Q3 2024 stood at $18.2 million, up from $15.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $20.3 million in Q4 2023, with the low at $4.3 million in Q4 2021.
- The 4-year median for Total Non-Current Liabilities is $14.7 million (2024), against an average of $11.7 million.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities surged 358.49% in 2023, then dropped 24.41% in 2024.
- Zura Bio's Total Non-Current Liabilities stood at $4.3 million in 2021, then gained by 3.4% to $4.4 million in 2022, then soared by 358.49% to $20.3 million in 2023, then retreated by 10.14% to $18.2 million in 2024.
- Business Quant data shows ZURA's Total Non-Current Liabilities at $18.2 million in Q3 2024, $15.1 million in Q2 2024, and $14.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 40.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.53 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.88 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.32 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 15.07 Mn |
| Mar 31, 2024 | 14.67 Mn |
| Dec 31, 2023 | 20.30 Mn |
| Sep 30, 2023 | 17.01 Mn |
| Jun 30, 2023 | 19.94 Mn |
| Dec 31, 2022 | 4.43 Mn |
| Sep 30, 2022 | 5.35 Mn |
| Jun 30, 2022 | 5.05 Mn |
| Mar 31, 2022 | 4.38 Mn |
| Dec 31, 2021 | 4.28 Mn |